Cardiology Research

Recognized nationally and internationally, the Cardiovascular Research Laboratory at Children’s Hospital of Pittsburgh of UPMC’s Rangos Research Center was designed to provide an environment in which researchers and clinicians could work side by side to study clinically relevant cardiovascular problems. The work here has gained worldwide respect and recognition in the field of congenital heart disease.

Congenital cardiovascular (CV) malformations represent one of the leading causes of morbidity and mortality in children and adults, however, it remains unclear how congenital CV malformations occur. Our research laboratories investigate the physiology and biomechanics of developing CV systems in chick and mouse embryos in order to better understand the structural and functional maturation of the normal heart and blood vessels and the causes for congenital heart disease.

Our laboratory has pioneered the integrated use of microinstruments to measure blood pressure, blood flow, and cardiac chamber dimensions in the 1 millimeter diameter embryonic heart. Because embryonic CV structural and functional maturation in chick and mouse embryos resembles human development, we can use these animal models to determine the relationship between biomechanical loading conditions and morphogenesis. For example, we have produced a model of hypoplastic left heart syndrome (HLHS) in the chick embryo by chronically reducing left ventricular filling via partial left-atrial ligation (LAL). We have also created experimental models of increased ventricular work via narrowing of the ventricular outflow tract (conotruncal banding - CTB) and by unilateral vitelline artery ligation (VAL).

In order to better understand the interactions between mother and fetus (in mammals) that may contribute to altered CV morphogenesis, we also investigate maternal and embryonic/fetal CV function in pregnant rodents using high resolution ultrasound as well as invasive techniques.

Our laboratory also serves as a core facility to determine CV structure and function in mature animals undergoing experimental protocols to evaluate
novel therapies (cells, materials, devices, software) to treat congenital and acquired heart disease.


Researchers

Clinical Studies

Vivekanand Allada, MD

Read more

Stacey E. Drant, MD

Read more

Brian David Feingold, MD

Read more

Jacqueline Kreutzer, MD, FAAC, FSCAI

Read more

Diane Metes, MD

Read more

Joan Sanchez-de-Toledo, MD, PhD

Read more

Adult Congenital Heart Disease Clinical Care Evaluation

Utilization and Perception of Care by Physician Extenders in the Adult Congenital Heart Disease Program

Read more

Aortic Coarctation Treatment with Covered CP Stent™ – COAST II

Covered Cheatham Platinum CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated with Coarctation of the Aorta (COAST II) – Continued Study Access

Read more

Aortic Coarctation Treatment with CP Stent™ – COAST

Coarctation of the Aorta Stent Trial (COAST) – Continued Study Access

Read more

Beta Blocker Therapy for Marfan Syndrome

Trial of Beta Blocker Therapy vs Angiotensin II Receptor Blocker Therapy in Individuals with Marfan Syndrome

Read more

Comparing Treatments for Coarctation of the Aorta

Comparison between Surgical vs. Balloon Angioplasty vs. Intravascular Stent Placement for Recurrent or Native Coarctation of the Aorta

Read more

Coping with Heart Disease – A Study of Adolescents and Adults

Coping Mechanisms, Gender Difference, and Cardiovascular Risk in Adolescents and Adults with Congenital Heart Disease

Read more

Dexmedetomidine for Sedation in Medical Procedures – Phase IV

Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Read more

Fontan Procedure Physiology

Do Serum Biochemical and Hematopoietic, or Stool Biomarkers Predict Low Cardiac Index in Patients with Fontan Physiology?

Read more

Pediatric Heart Transplant - Alloantibodies Detection

Alloantibodies: Prevalence and Impact in Pediatric Heart Transplantation

Read more

Pediatric Heart Transplant - Alloantibodies Impact Study

Alloantibodies in Pediatric Heart Transplantation

Read more

Pediatric Heart Transplant - Fibrosis Quantification Study

MRI Quantification of Cardiac Fibrosis after Heart Transplantation

Read more

Sexual Dysfunction and Congenital Heart Disease – Pilot Study

Female Sexual Dysfunction Among Adults with Complex Congenital Heart Disease

Read more

SVT Treatment with Dexmedetomidine

Dexmedetomidine vs. Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia

Read more

Transplant EBV Disease Study

Transplant Epstein-Barr Virus (EBV) Disease – Pathogenesis and Immunotherapy

Read more

Treating Atrial Septal Defects with Amplatzer

Closure of Atrial Septal Defects with the Amplatzer® Septal Occluder Post Market Study

Read more
Our Researchers

Li Jun Liu, MD
David Rowe, PhD
Kimimasa Tobia, MD